Clinical Trial: Exploratory Clinical Study on the Safety of STR-P004 in the Treatment of Patients With Relapsed or Refractory Autoimmune Diseases

U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07143617) titled 'Exploratory Clinical Study on the Safety of STR-P004 in the Treatment of Patients With Relapsed or Refractory Autoimmune Diseases' on Aug. 20.

Brief Summary: This is an open-label, multiple-dose escalation IIT clinical study aimed at evaluating the safety, tolerability, PK, and preliminary efficacy of STR-P004 in adult patients with relapsed or refractory autoimmune diseases.

Study Start Date: Sept. 15

Study Type: INTERVENTIONAL

Condition: Autoimmune Diseases

Intervention: BIOLOGICAL: STR-P004

STR-P004 Intravenous infusion

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Beijing GoBroad Hospital

Information provided by (Res...